Healthcare -
Biotechnology - NASDAQ - FR
$ 1.69
1.2 %
$ 142 M
Market Cap
-3.93
P/E
IPHA - CAPITAL EXPENDITURES
Capital Expenditures IPHA - Innate Pharma S.A.
-2.35 M
LAST VALUE
-32.95%
2 YEAR CAGR
-10.47%
5 YEAR CAGR
-18.43%
10 YEAR CAGR